Desert King
Is this your company? Claim this profile
Excipients & Specialty Ingredients
Clinical Trial Supply & Logistics
Advanced Modalities
Analytical & Bioanalytical Services
Drug Product
Company Overview
About
Desert King is a Chilean-headquartered company dedicated to the sustainable production and supply of high-purity botanical extracts from Quillaja saponaria and Yucca schidigera. They are world leaders in QS-21 adjuvant production, a critical component in approved vaccines for malaria, shingles, COVID-19, and RSV by manufacturers like GSK and Novavax. Desert King supplies raw material ingredients, not finished drug products.
Key Expertise
QS-21 adjuvant, Quillaja saponin extracts, vaccine adjuvant supply, botanical extracts
Quick Facts
HQ:Chile
Capabilities & Services
Markets Served
Latin America
North America
South America
Manufacturing Facilities
3 sites worldwide
Desert King - Chile Facility
Chile
Site Capabilities
3 capabilitiesBiologics Manufacturing
Monoclonal Antibodies
Vaccines
Desert King - Mexico Facility
Mexico
Site Capabilities
3 capabilitiesBiologics Manufacturing
Monoclonal Antibodies
Vaccines
Desert King - United States Facility
United States
Site Capabilities
3 capabilitiesBiologics Manufacturing
Monoclonal Antibodies
Vaccines